Status:
COMPLETED
Circumferential Versus Ganglionated Plexi Ablation for Atrial Fibrillation (AF)
Lead Sponsor:
Cardiovascular Research Society, Greece
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The investigators have recently shown that anatomic ganglionated plexi (GP) ablation is inferior to circumferential pulmonary vein (PV) ablation for the treatment of paroxysmal AF. In this study, howe...
Detailed Description
Introduction: In clinical studies, epicardial or endocardial partial ganglionated plexi (GP) ablation may prevent AF,1-4 and parasympathetic denervation has been proposed as a potential mechanism of ...
Eligibility Criteria
Inclusion
- paroxysmal AF
- age \< 75 years
- left atrial size \< 5 cm
Exclusion
- malignancies
- LVEF \< 35%
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2011
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00671905
Start Date
May 1 2008
End Date
August 1 2011
Last Update
April 11 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Athens Euroclinic
Athens, Greece, 11521
2
State Research Institute of Circulation Pathology
Novosibirsk, Russia